Recently, YAP1 (a nuclear effector of an inactivated HIPPO pathway) has been recognized as a potent oncogene closely linked to the prognosis and progression of several types of cancer, including breast and pancreatic cancer (18, 19). This evidence concerns the gene YAP1 and familial pancreatic carcinoma.